The Oxford Science Park announces further expansion and appoints DTRE as joint advisors
- The Oxford Science Park (TOSP), one of Europe’s leading locations for research-led science and technology companies, has appointed DTRE as joint leasing advisor.
- Majority-owned by Magdalen College, Oxford, TOSP operates over 600,000 sq. ft. of office and laboratory space with a further 650,000 sq. ft. under development.
- TOSP is home to close to 100 leading companies focused on life science and technology, ranging from early-stage spinouts to major international businesses.
LONDON, UK – The Oxford Science Park (TOSP), one of the world’s leading powerhouses for science and technology companies, has instructed DTRE as joint advisors with Cushman & Wakefield to advise on and manage the leasing of over 600,000 sq. ft. of office and laboratory space, as well as future developments totalling over 650,000 sq. ft.
With demand for laboratories in the UK fast outpacing supply, TOSP is playing a central role in the UK’s race for specialist space as the country seeks to achieve its ambition of becoming a science superpower.
The newly-completed Iversen Building, which provides 88,000 sq. ft. of genuinely lab-ready space, is the latest addition to the Park. It joins 15 other high-quality properties within TOSP, which are available to bespoke specifications, with adaptable layouts to facilitate the full spectrum of laboratory and office requirements.
The world’s leading academic institution for the last seven years, Oxford University excels in the fields of medical science, biochemistry and computer science. The university is the UK’s most prolific filer of patents and has received the largest share of funding grants in recent years. In recent decades it has seen over 150 life science spinouts including Oxford Nanopore, which is based at the Park.
TOSP sits just three miles from this community and less than an hour from London’s expansive network of initiators and investors. It is already home to close to 100 leading research-led companies, many of which played a critical role in the fight against COVID-19.
The Park is also the new Oxford home for the Ellison Institute of Technology, a major international research and development organisation which is seeking to accelerate innovation in medical science and healthcare, food security and sustainable agriculture, clean energy and climate change, and government policy and economics.
Commenting on the announcement, Rory Maw, CEO of The Oxford Science Park, said: “We are delighted to be working with DTRE as the Park enters an exciting phase of development. With the Iversen Building now completed, we have already started work on three major lab-ready buildings totalling 450,000 sq. ft. for delivery in 2026. This will take total space on the Park to over 1.0 million sq. ft. and provide badly-needed space for the next generation of life science and technology companies.”
“The enormous demand for specialist space in the UK is showing no signs of waning and The Oxford Science Park has been essential to filling the supply void,” said Matt Smith, Head of Science & Technology at DTRE. “Its proximity to the Oxford biotech and technology communities is hard to beat but, perhaps more importantly, the array of facilities within the Park means it is able to cater for occupiers from conception to commercialisation, making it an ideal home for both early-stage spinouts and multinationals.”
DTRE is an award-winning, independent commercial property adviser specialising in industrials, logistics, science & technology, and offices. The Science and Technology team operates across the Golden Triangle and has been instructed by the likes of BioMed Realty, Mission Street, Kadans Science Partner, Abstract Securities, LS Estates and Oaktree to provide data-driven leasing strategy and development advisory services across four million square feet of research and development space.
Wrapping over three decades of blue-chip experience into a more focused, differentiated, data-driven platform, DTRE delivers specialised investment, development, and leasing advice to clients throughout the UK and Europe.
About The Oxford Science Park
The Oxford Science Park is majority-owned and managed by Magdalen College, Oxford. Created in 1991, the Park upholds the College’s heritage and provides one of the most influential science & technology environments in the UK. There is approaching 750,000 sq. ft. of office and laboratory accommodation across the Park, which is now home to over 3,000 people and close to 100 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Blue Earth Diagnostics, Oxford Nanopore Technologies, OXGENE, ProImmune, Oxford Science Enterprises, Enara Bio, Sitryx, Ochre Bio, Scancell, Evox Therapeutics, Exscientia, and Intuitive Surgical.
In addition to being a key property investment, the Park is at the heart of Magdalen College's strategy to support discovery, innovation and entrepreneurship. It will continue to develop The Oxford Science Park as a long-term strategic asset. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos. The Oxford Science Park is located approximately three miles south-east of Oxford city centre, just off the city’s southern ring road. It has easy access to the M40 and A34, as well as to Heathrow Airport and mainline train services. For further information, please visit: www.oxfordsp.com or follow us on Twitter @OxfordSciencePK.
About DTRE
DTRE is an award-winning, independent commercial property adviser specialising in industrials, logistics, science & technology, and offices. Wrapping over three decades of blue-chip experience into a more focused, differentiated, data-driven platform, DTRE delivers specialised investment, development, and leasing advice to clients throughout the UK and Europe.
Leveraging its proprietary data platform (Coyote) and market leading research, DTRE provides clients with unparalleled insights and analysis for informed decision-making tailored to their unique needs and challenges. Since being established in 2010, DTRE has provided expert counsel on sales and acquisitions valued in excess of £26 billion.
Media Contacts
Harry Roxburgh
hroxburgh@nepean.co.uk | +44 7814 372664
